Screener
Nektar Therapeutics NKTR Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
FAQ
- What is Nektar Therapeutics's gross margin?
- Nektar Therapeutics (NKTR) reported gross margin of 100% in Q4 2025.
- How has Nektar Therapeutics's gross margin changed year-over-year?
- Nektar Therapeutics's gross margin increased by 45.3% year-over-year, from 68.8% to 100%.
- What is the long-term trend for Nektar Therapeutics's gross margin?
- Over 5 years (2020 to 2025), Nektar Therapeutics's gross margin has grown at a 2.8% compound annual growth rate (CAGR), from 87.3% to 100%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Nektar Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude